全球体外二氧化碳去除装置市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

预计到 2032 年，全球体外二氧化碳去除设备市场的市场规模将从 2023 年的 85.73 万美元达到近 174.41 万美元，2024 年至 2032 年研究期间的CAGR为 8.21%。

体外二氧化碳移除装置是专门设计用于消除体外血液中二氧化碳 (CO2) 的医疗器材。这些设备在体外生命支持（ECLS）或体外膜氧合（ECMO）领域中发挥着至关重要的作用，为面临严重呼吸衰竭或急性呼吸窘迫症候群（ARDS）的患者提供临时援助。此技术的主要目标是减轻肺部压力，促进癒合，同时确保足够的氧合和二氧化碳去除。

市场动态

在多种因素的推动下，体外二氧化碳去除装置市场正在大幅成长。严重呼吸衰竭、急性呼吸窘迫症候群 (ARDS) 和呼吸系统疾病的盛行率不断上升，增加了对这些设备的需求，为对常规通气无反应的患者提供了重要的治疗途径。技术进步在市场扩张中发挥关键作用，设备设计和薄膜技术的不断创新提高了效率和效果。这些进步有助于开发更复杂的设备，提高重症监护环境中的性能、安全性和适用性。随着医疗保健专业人员认识到管理严重呼吸系统疾病在提供肺部休息和支持方面的作用，人们越来越意识到管理严重呼吸系统疾病的好处，这有助于市场成长。包括慢性阻塞性肺病（COPD）在内的呼吸系统疾病的发生率不断上升，增加了对这些支持性干预措施的需求。 COVID-19 大流行进一步强调了先进呼吸支援系统（包括这些设备）在管理严重呼吸窘迫方面的重要性。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球体外二氧化碳去除设备市场的各个细分市场进行了包容性评估。体外二氧化碳去除装置产业的成长和趋势为本研究提供了整体方法。

市场区隔

体外二氧化碳去除装置市场报告的这一部分提供了国家和区域层面的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

• 体外二氧化碳机
• 免洗用品
• 其他的

按应用

• 急性呼吸窘迫症候群（Ards）
• 慢性阻塞性肺病（COPD）
• 肺移植桥
• 其他的

透过访问

• 静脉
• 动静脉

按最终用途

• 医院
• 门诊手术中心
• 诊所
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲体外二氧化碳去除设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。体外二氧化碳去除设备市场的主要参与者包括 Medtronic、Getinge AB、Xenios AG、ALung Technologies, Inc.、ESTOR SPA、Medica SPA、Aferetica srl。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：体外二氧化碳移除装置 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按访问进行的市场吸引力分析
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球体外二氧化碳移除装置市场分析：依产品

• 按产品概述
• 历史和预测数据
• 按产品分析
• 体外二氧化碳机
• 免洗用品
• 其他的

第 6 章：全球体外二氧化碳移除装置市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 急性呼吸窘迫症候群（ARDS）
• 慢性阻塞性肺病（COPD）
• 肺移植桥
• 其他的

第 7 章：全球体外二氧化碳移除装置市场分析：按访问方式

• 按访问方式概述
• 历史和预测数据
• 透过访问进行分析
• 静脉
• 动静脉

第 8 章：全球体外二氧化碳移除装置市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 医院
• 门诊手术中心
• 诊所
• 其他的

第 9 章：全球体外二氧化碳移除装置市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：体外二氧化碳移除装置公司的竞争格局

• 体外二氧化碳去除装置市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 公司股份分析
• 市场集中度
• Medtronic
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Getinge AB
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Xenios AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• ALung Technologies Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• ESTOR SPA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Medica SPA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Aferetica srl
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Extracorporeal CO2 Removal Devices Market is presumed to reach the market size of nearly USD 174.41 MN by 2032 from USD 85.73 MN in 2023 with a CAGR of 8.21% under the study period 2024 - 2032.

Extracorporeal carbon dioxide removal devices are medical instruments specifically engineered to eliminate carbon dioxide (CO2) from the bloodstream external to the body. These devices play a crucial role in the realm of extracorporeal life support (ECLS) or extracorporeal membrane oxygenation (ECMO), providing temporary assistance to patients facing severe respiratory failure or acute respiratory distress syndrome (ARDS). The primary objective of this technology is to alleviate the strain on the lungs, allowing for healing while ensuring sufficient oxygenation and CO2 removal.

MARKET DYNAMICS

The market for extracorporeal carbon dioxide removal devices is witnessing substantial growth, driven by various factors. The escalating prevalence of severe respiratory failure, acute respiratory distress syndrome (ARDS), and respiratory conditions are amplifying the demand for these devices, offering a critical therapeutic avenue for patients unresponsive to conventional ventilation. Technological advancements play a pivotal role in market expansion, with continuous innovations in device design and membrane technology enhancing efficiency and effectiveness. These advancements contribute to the development of more sophisticated devices that improve performance, safety, and applicability in critical care settings. The increasing awareness of the benefits of managing severe respiratory conditions is contributing to market growth as healthcare professionals recognize its role in providing lung rest and support. The rising incidence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), adds to the demand for these supportive interventions. The COVID-19 pandemic has further emphasized the importance of advanced respiratory support systems, including these devices, in managing severe respiratory distress.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extracorporeal co2 removal devices. The growth and trends of extracorporeal co2 removal devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the extracorporeal co2 removal devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Extracorporeal CO2 Machines
• Disposables
• Others

By Application

• Acute Respiratory Distress Syndrome (Ards)
• Chronic Obstructive Pulmonary Disease (Copd)
• Bridge To Lung Transplant
• Others

By Access

• Venovenous
• Arteriovenous

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Extracorporeal CO2 Removal Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extracorporeal CO2 Removal Devices market include Medtronic, Getinge AB, Xenios AG, ALung Technologies, Inc., ESTOR S.P.A., Medica S.P.A., Aferetica srl. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . EXTRACORPOREAL CO2 REMOVAL DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Access
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Extracorporeal CO2 Machines Historic and Forecast Sales by Regions
• 5.5 Disposables Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Acute Respiratory Distress Syndrome (ARDS) Historic and Forecast Sales by Regions
• 6.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
• 6.6 Bridge to Lung Transplant Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY ACCESS

• 7.1 Overview by Access
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Access
• 7.4 Venovenous Historic and Forecast Sales by Regions
• 7.5 Arteriovenous Historic and Forecast Sales by Regions

8 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY END-USE

• 8.1 Overview by End-use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-use
• 8.4 Hospitals Historic and Forecast Sales by Regions
• 8.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
• 8.6 Clinics Historic and Forecast Sales by Regions
• 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE EXTRACORPOREAL CO2 REMOVAL DEVICES COMPANIES

• 10.1. Extracorporeal Co2 Removal Devices Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF EXTRACORPOREAL CO2 REMOVAL DEVICES INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Medtronic
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Getinge AB
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Xenios AG
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. ALung Technologies Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. ESTOR S.P.A.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Medica S.P.A.
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Aferetica srl
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Extracorporeal CO2 Machines Market Sales by Geography (USD MN)
• Disposables Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Acute Respiratory Distress Syndrome (ARDS) Market Sales by Geography (USD MN)
• Chronic Obstructive Pulmonary Disease (COPD) Market Sales by Geography (USD MN)
• Bridge to Lung Transplant Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by Access (USD MN)
• Venovenous Market Sales by Geography (USD MN)
• Arteriovenous Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Extracorporeal Co2 Removal Devices Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Extracorporeal Co2 Removal Devices Report
• Market Research Process
• Market Research Methodology
• Global Extracorporeal Co2 Removal Devices Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Access
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Extracorporeal CO2 Machines Market Sales by Geography (USD MN)
• Disposables Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Acute Respiratory Distress Syndrome (ARDS) Market Sales by Geography (USD MN)
• Chronic Obstructive Pulmonary Disease (COPD) Market Sales by Geography (USD MN)
• Bridge to Lung Transplant Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Access (USD MN)
• Venovenous Market Sales by Geography (USD MN)
• Arteriovenous Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.